⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL6470627 | 0.96 | CYP2D6 (0.35) | — | |
| Iodide SCHEMBL7849934 | 0.96 | CYP2D6 (0.35) | — | |
| SCHEMBL3070710 | 0.92 | — | — | |
| SCHEMBL1553028 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL23296440 | 0.88 | CYP2D6 (0.35) | — | |
| SCHEMBL24098344 | 0.82 | CYP2D6 (0.32) | — | |
| SCHEMBL13594206 | 0.79 | — | — | |
| SCHEMBL22572378 | 0.79 | FDPS (0.31) | — | |
| SCHEMBL22173799 | 0.79 | FDPS (0.35) | — | |
| SCHEMBL6333392 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112533902-B | Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers | 埃科莱布美国股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-221950628-U | Continuous purification system of diethyl hydroxylamine | 济宁康德瑞化工科技有限公司 | 2024-11-05 | — | — | CN | disclosed |
| EP-4332169-A2 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | The Boeing Company (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-3820846-B1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | ECOLAB USA INC (US) | 2024-01-03 | — | — | EP | disclosed |
| CN-112220797-B | C/EBP alpha compositions and methods of use | 米纳治疗有限公司 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023126312-A1 | DISPERSANT | BASF COATINGS GMBH (DE) | 2023-07-06 | — | — | WO | disclosed |
| CN-110573490-B | Polymerizable compound and liquid crystal composition | DIC株式会社（JP） | 2023-01-13 | — | — | CN | disclosed |
| CN-115594820-A | Functionalized Mxenes modified biomass-based polyurea and preparation method and coating thereof | 湖北工业大学（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-114763357-A | Indolopyrimidine tricyclic compound and preparation method and application thereof | 中国科学院上海药物研究所 | 2022-07-19 | — | — | CN | disclosed |
| CN-108472358-B | Nucleic acid derivatives with immunopotentiating activity | 盐野义制药株式会社 | 2022-06-24 | — | — | CN | disclosed |
| US-20040067966-A1 | Adenosine receptor antagonists and methods of making and using the same | BIOGEN, INC. | 2004-04-08 | — | — | US | disclosed |
| US-20030220495-A1 | Inhibitors of farnesyl protein transferase | ZENECA LIMITED AND ZENECA PHARMA S.A. | 2003-11-27 | — | — | US | disclosed |
| US-6649600-B1 | 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics | BIOGEN, INC. | 2003-11-18 | — | — | US | disclosed |
| CN-1402729-A | Polycycloalkylpurines as adenosine receptor antagonists | BIOGEN INC (US) | 2003-03-12 | — | — | CN | disclosed |
| EP-1230243-A1 | POYCYLOALKYLPURINES AS ADENOSINE RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 2002-08-14 | — | — | EP | disclosed |
| US-6414145-B1 | TREATING CANCER AND NEUROFIBROMATOSIS | ZENECA LIMITED (GB) | 2002-07-02 | — | — | US | disclosed |
| WO-2001034610-A1 | POLYCYCLOALKYLPURINES AS ADENOSINE RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 2001-05-17 | — | — | WO | disclosed |
| EP-0975603-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998032741-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 1998-07-30 | — | — | WO | disclosed |
| US-5218002-A | Morpholinoureas | BAYER AKTIENGESELLSCHAFT (DE) | 1993-06-08 | — | — | US | disclosed |